MyAverix Finance
F · Healthcare
LAVIPHARM S.A. NA EO 1 (BXA0)
Drug Manufacturers - Specialty & Generic
LAVIPHARM S.A. NA EO 1 (BXA0) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $197.43M, P/E ratio is 105.80, net margin is 9.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BXA0
LAVIPHARM S.A. NA EO 1 (BXA0) — FAQ
What is LAVIPHARM S.A. NA EO 1's market cap?
LAVIPHARM S.A. NA EO 1 (BXA0) has a reported market cap of $197.43M (data as of 2026-03-28).
What is BXA0's P/E ratio?
The price-to-earnings (P/E) ratio for LAVIPHARM S.A. NA EO 1 (BXA0) is 105.80 (data as of 2026-03-28).
Does LAVIPHARM S.A. NA EO 1 pay a dividend?
Dividend yield is not available in the current snapshot for LAVIPHARM S.A. NA EO 1 (BXA0). Check the MyAverix Finance app for the latest dividend data.
What sector is LAVIPHARM S.A. NA EO 1 in?
LAVIPHARM S.A. NA EO 1 (BXA0) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BXA0 listed on?
BXA0 is listed on F.
What is LAVIPHARM S.A. NA EO 1's net margin?
LAVIPHARM S.A. NA EO 1 (BXA0) reports a net margin of 9.6% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.